… to enhance the antitumor activity by reducing the side effects of chemotherapy, minimizing
systemic toxicity, … for NPC patients with primary or secondary chemo-resistance in the future. …

… However, the positive chemotherapeutic effect of cisplatin in most cancers (eg, ovarian, …
iron oxide nanoparticles (<10 nm) loaded with cisplatin (IV) prodrug compared to using cisplatin. …

… strategy to enhance the anticancer efficacy of cisplatin via a chemotherapeutic agent 4.5…
-inflammation and assisting cisplatin in accelerating tumor toxicity via ROS generation in tumor …

… to generation of reactive oxygen species (ROS) to enhance … lower systemic toxicity compared
to cisplatin. Additionally, Pt-… cells as cisplatin is the first-line chemotherapeutic drug in …

… Superparamagnetic iron oxide nanoparticles were … for enhancing the therapeutic index
while reducing side effects. In … delivery application is its negligible toxicity to normal cells. The …

… which may result in an improved and localized drug release mechanism … and less toxic during
circulation than cisplatin providing … of side effects associated to the treatment with cisplatin. …

… Various novel nanocarrier-mediated drug delivery systems to … , Sorafenib and Cisplatin
chemotherapeutic agents. Citation… imaging of iron oxide nanoparticles based chemotherapy. (A…

… in combining cisplatin with TAT-peptide to enhance cisplatin … curative effects and minimized
side effects by reducing CDDP … the increased intracellular uptake of CDDP, while the toxicity …

… Traditional treatments, such as with the chemotherapy drug cisplatin, encounter … Enhanced
Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic …

… multiple advantages over free drugs, including reduced systemic toxicity, improved passive
accumulation in the tumor due to the enhanced permeability and retention (EPR) effects and …